Company Filing History:
3 out of 504 
3 out of 497 
3 out of 8,686 
Years Active: 2016-2020
Title: Jayne F Koellhoffer: Innovator in Filovirus Research
Introduction
Jayne F Koellhoffer is a prominent inventor based in New York, NY (US), known for her significant contributions to the field of filovirus research. With a total of three patents to her name, she has made strides in developing therapies and antibodies that address critical health challenges posed by filovirus infections.
Latest Patents
Koellhoffer's latest patents include groundbreaking inventions aimed at combating filovirus infections. One of her notable patents focuses on a filovirus antibody that addresses the need for effective antibodies useful in treating these infections. Another patent presents a therapy for filovirus infection, which provides an isolated humanized anti-filovirus glycoprotein pre-fusion core antibody. This antibody comprises a framework region with a sequence of 95% or greater identity to a human antibody framework region. Additionally, her inventions include methods for treating and inhibiting filovirus infections in subjects by administering the described antibodies or their antigen-binding fragments. The compositions developed also include pharmaceutically acceptable carriers.
Career Highlights
Throughout her career, Koellhoffer has worked with esteemed institutions such as the Albert Einstein College of Medicine and the University of Toronto. Her work in these organizations has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Koellhoffer has collaborated with notable colleagues, including Jonathan R Lai and Julia Frei. These partnerships have further enriched her research endeavors and have played a role in her innovative contributions to filovirus research.
Conclusion
Jayne F Koellhoffer's work in developing therapies and antibodies for filovirus infections showcases her dedication to addressing critical health issues. Her patents and collaborations reflect her commitment to advancing medical science and improving treatment options for patients.